In this study, to systematically identify the targets of TFEB, we produced stably wild-type TFEB (TFEBWT)- or activated-status TFEB (TFEBS142A/S138A)-expressing CRC cells and quantitatively analyzed the proteomes of these cells. Here, TFEB is linked to colorectal carcinoma.